WebIt is currently -92.09% from its 52-week high and 36.92% from its 52-week low. How much is Biora Therapeutics stock worth today? ( NASDAQ: BIOR) Biora Therapeutics currently has 7,616,512 outstanding shares. With Biora Therapeutics stock trading at $2.67 per share, the total value of Biora Therapeutics stock (market capitalization) is $20.34M. WebThe latest price target for . Biora Therapeutics (NASDAQ: BIOR) was reported by HC Wainwright & Co. on January 10, 2024.The analyst firm set a price target for $65.00 expecting BIOR to rise to ...
Biora Therapeutics, Inc. (BIOR) Price To Free Cash Flow - Zacks.com
WebMar 24, 2024 · Biora Therapeutics, Inc., formerly Progenity, Inc., is a biotechnology company focused on developing oral biotherapeutics. It delivers therapeutics in two areas: targeted delivery of therapeutics to the site of disease in the gastrointestinal tract and systemic delivery of biotherapeutics. Its research and development pipeline consists of … Web22 votes and 7 comments so far on Reddit inappropriate snacks
Biora Therapeutics - BIOR Stock Forecast, Price & News - MarketBeat
WebFeb 23, 2024 · Biora Therapeutics (Nasdaq:BIOR) earnings and revenue forecasts, price targets, future return on equity. ... (NASDAQ:PROG) Price Target To US$8.00 Mar 20. Full year 2024 earnings released: US$7.01 loss per share (vs US$46.87 loss in FY 2024) Mar 20. Progenity, Inc. to Report Q4, 2024 Results on Mar 18, 2024 Mar 13. WebDec 31, 2024 · BIOR US74319F3055. BIORA THERAPEUTICS, INC. (BIOR) Add to my list. Report. Delayed ... HC Wainwright Adjusts Price Target on Biora Therapeutics to $6 From $4, Reiterates Buy .. MT. 2024: Correction: BTIG Analyst Assumes Biora Therapeutics at Buy, Price Target $4: MT. WebThe target price for BIOR stock is $65 based on the average of what a group of analyst think BIOR stock could be worth at a future date. This is not a prediction by Public.com … inappropriate sinus tachycardia treatments